Yasuhiro FUNAHASHI,Bruce A. Littlefield,Toshimitsu UENAKA
申请号：
US15123476
公开号：
US20170071903A1
申请日:
2015.03.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Methods for treating cancer (e.g., breast cancer, lung cancer, pancreatic cancer, primitive neuroectodermal tumors, lung cancer, ovarian cancer, endometrial cancer, pharyngeal cancer, esophageal cancer, and sarcoma) in a subject (such as an human patient) in need thereof by administering eribulin (e.g., eribulin mesylate, i.e., E7389, Halaven) in combination with one or more mammalian target of rapamycin (mTOR) inhibitors (e.g., everolimus, ridaforolimus, and temsirolimus), and kits therefor are provided.
